(Q40748918)

23 September 2017

1 reference

title

Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. (English)

1 reference

23 September 2017

0 references

Lindhout D

1

1 reference

23 September 2017

Omtzigt JG

series ordinal

2

1 reference

23 September 2017

publication date

1 January 1994

1 reference

23 September 2017

1 reference

23 September 2017

volume

35 Suppl 4

1 reference

23 September 2017

page(s)

S19-28

1 reference

Convulsions in epileptic women after administration of prostaglandin E2 derivative

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Minor anomalies in offspring of epileptic mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Intelligence of children of epileptic mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Teratogen update: fetal hydantoin effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

In-utero exposure to valproate and neural tube defects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Prenatal diagnosis of spina bifida aperta after first‐trimester valproate exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Valproate and spina bifida

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Genetic predisposition to phenytoin-induced birth defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

Diurnal variation of folate concentrations in mouse embryo and plasma: The protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

The role of ultrasound in the early diagnosis of fetal structural defects following maternal anticonvulsant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1157.1994.TB05952.X

10.1111/J.1528-1157.1994.TB05952.X

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference